Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration

ABSTRACT:

SUBMITTER: Hatz K 

PROVIDER: S-EPMC11989833 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature